IBRN vs. PBPH
IBRN (iShares Neuroscience and Healthcare ETF) and PBPH (Portfolio Building Block World Pharma and Biotech Index ETF) are both Health & Biotech Equities funds - IBRN tracks the NYSE FactSet Global Neuro Biopharma and MedTech Index while PBPH tracks the BITA Global Pharma and Biotech Select Index. Both are passively managed. Their 0.57 correlation means they have sometimes moved together and sometimes differently. IBRN charges 0.47%/yr vs 0.13%/yr for PBPH.
Performance
IBRN vs. PBPH - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, IBRN achieves a 13.26% return, which is significantly higher than PBPH's 7.71% return.
IBRN
- 1D
- -3.24%
- 1M
- -6.28%
- 6M
- 12.31%
- YTD
- 13.26%
- 1Y
- 59.23%
- 3Y*
- 14.57%
- 5Y*
- —
- 10Y*
- —
- ALL TIME*
- 10.28%
PBPH
- 1D
- -1.24%
- 1M
- -2.58%
- 6M
- 4.02%
- YTD
- 7.71%
- 1Y
- —
- 3Y*
- —
- 5Y*
- —
- 10Y*
- —
- ALL TIME*
- —
Liquidity Comparison
| Position | Avg. Volume Value (2W) | Avg. Volume Value (1M) | Avg. Volume Value (3M) |
|---|---|---|---|
| $83.61K | $123.63K | $97.37K | |
| $2.67M | $4.96M | $3.73M |
IBRN vs. PBPH - Yearly Performance Comparison
| 2026 (YTD) | 2025 | |
|---|---|---|
IBRN iShares Neuroscience and Healthcare ETF | 13.26% | 6.61% |
PBPH Portfolio Building Block World Pharma and Biotech Index ETF | 7.71% | 0.74% |
Correlation
The correlation between IBRN and PBPH is 0.57, which is moderate. They have sometimes moved together and sometimes differently, sharing some price drivers without tracking each other closely.
| Correlation | |
|---|---|
Correlation (All Time) Calculated using the full available price history since Nov 25, 2025 | 0.57 |
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
IBRN vs. PBPH — Risk / Return Rank
IBRN
PBPH
Risk / return metrics aren't available yet — we need at least 12 months of trading data to calculate them.
IBRN vs. PBPH - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for iShares Neuroscience and Healthcare ETF (IBRN) and Portfolio Building Block World Pharma and Biotech Index ETF (PBPH). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| IBRN | PBPH | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | — | — | |
| Sortino ratioReturn per unit of downside risk | — | — | |
| Omega ratioGain probability vs. loss probability | 1.36 | — | — |
| Calmar ratioReturn relative to maximum drawdown | 6.42 | — | — |
| Martin ratioReturn relative to average drawdown | 16.74 | — | — |
Loading charts...
Drawdowns
IBRN vs. PBPH - Drawdown Comparison
The maximum IBRN drawdown since its inception was -35.38%, which is greater than PBPH's maximum drawdown of -11.10%. Use the drawdown chart below to compare losses from any high point for IBRN and PBPH.
Loading charts...
Drawdown Indicators
| IBRN | PBPH | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -35.38% | -11.10% | -24.28% |
Max Drawdown (1Y)Largest decline over 1 year | -9.15% | — | — |
Max Drawdown (3Y)Largest decline over 3 years | -35.38% | — | — |
Current DrawdownCurrent decline from peak | -9.15% | -3.03% | -6.12% |
Average DrawdownAverage peak-to-trough decline | -9.59% | -4.04% | -5.55% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 3.50% | — | — |
Volatility
IBRN vs. PBPH - Volatility Comparison
Loading charts...
Volatility by Period
| IBRN | PBPH | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 7.68% | — | — |
Volatility (6M)Calculated over the trailing 6-month period | 19.64% | — | — |
Volatility (1Y)Calculated over the trailing 1-year period | 25.61% | 17.84% | +7.77% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 25.34% | 17.84% | +7.50% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 25.34% | 17.84% | +7.50% |
IBRN vs. PBPH - Expense Ratio Comparison
IBRN has a 0.47% expense ratio, which is higher than PBPH's 0.13% expense ratio.
Dividends
IBRN vs. PBPH - Dividend Comparison
IBRN's dividend yield for the trailing twelve months is around 0.87%, more than PBPH's 0.08% yield.
| Position | TTM | 2025 | 2024 | 2023 |
|---|---|---|---|---|
IBRN iShares Neuroscience and Healthcare ETF | 0.87% | 0.99% | 0.40% | 0.06% |
PBPH Portfolio Building Block World Pharma and Biotech Index ETF | 0.08% | 0.09% | 0.00% | 0.00% |
Frequently Asked Questions
IBRN and PBPH have a correlation of 0.57, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
On fees, PBPH is cheaper at 0.13% per year. The better choice depends on whether you care most about return, fees, risk, or income.
PBPH is cheaper with a 0.13% expense ratio, compared with 0.47% for IBRN.
IBRN has the higher dividend yield at 0.87%, compared with 0.08% for PBPH.
IBRN tracks NYSE FactSet Global Neuro Biopharma and MedTech Index, while PBPH tracks BITA Global Pharma and Biotech Select Index. They also come from different issuers: iShares and Portfolio Building Block. Their fees differ too: 0.47% for IBRN and 0.13% for PBPH.
Find the right allocation for IBRN and PBPH
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer